Published in Vaccine Weekly, January 27th, 2010
The trial is being conducted in northern Ghana, Africa, and has reached the milestone of the nearly 1,000 infants in the study having received the second of two doses of either RotaShield or a placebo. This is the final rotavirus vaccination for these infants and their health will be closely monitored over the next year to determine the efficacy of the vaccine in preventing life-threatening...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly